Skip to content
Screener

GeneDx Holdings WGS Long-Term Debt

Long-Term Debt at other companies

NeoGenomics logo
NeoGenomicsNEO
$374.24M
Quest Diagnostics logo
Quest DiagnosticsDGX
$5.63B+9.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$802.9M-33.1%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$46.82M+0.1%
Labcorp Holdings logo
Labcorp HoldingsLH
$5.86B+15.4%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$61.36M-8.3%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemMarch 31, 2026 (Unaudited)December 31, 2025
Short-term lease liabilities5,1294,404
Other current liabilities35,94846,859
Total current liabilities87,639108,908
Long-term debt, net of current portion96,73248,176
Long-term lease liabilities66,33156,046
Other liabilities711,641
Deferred taxes1,404757
Total liabilities252,177215,528

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's long-term debt?
GeneDx Holdings (WGS) reported long-term debt of $96.73M in Q1 2026.
How has GeneDx Holdings's long-term debt changed year-over-year?
GeneDx Holdings's long-term debt increased by 86.8% year-over-year, from $51.79M to $96.73M.
What is the long-term trend for GeneDx Holdings's long-term debt?
Over 5 years (2020 to 2025), GeneDx Holdings's long-term debt has grown at a 20.5% compound annual growth rate (CAGR), from $18.97M to $48.18M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Ask your AI about GeneDx Holdings's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude